Toronto, Canada
BenchSci, founded in 2015, is a Canada-based startup at the intersection of AI, Biotechnology, and Life Sciences. The company's mission is articulated in its slogan: "We empower scientists with the world's most advanced biomedical artificial intelligence." Its platform is utilized by 16 of the top 20 pharmaceutical companies, evidencing significant market penetration and trust.
The company has garnered substantial investor confidence, as indicated by its latest $95.00M Series D round on 01 May 2023, supported by notable investors like Golden Ventures, F-Prime Capital, iNovia Capital, Generation Investment Management, and TCV. This funding underscores its scalability potential and innovation leadership within a competitive industry.
With recognition from accolades such as Deloitte Tech Fast 50, CIX Top 10 Growth, and Great Place to Work, BenchSci exemplifies both promising growth metrics and a strong cultural ethos, making it an attractive prospect for forward-thinking investors.
-logo.jpg "European Research Council (ERC)"){kind=logo}
Scientist.com